Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of novel chalcone derivatives for the treatment of neurodegenerative disorders

Dec. 22, 2021

Discovery of a familial intracranial aneurysm gene

Dec. 22, 2021

OAB-14 restores dysfunction of endosomal-autophagic-lysosomal pathway in APP/PS1 mice

Dec. 22, 2021

CD123 x CD3 bispecific Dart molecule MGD-024 active with other agents in AML models

Dec. 22, 2021

New dihydroorotate dehydrogenase inhibitors described by Medshine Discovery

Dec. 22, 2021

Nanjing Chia Tai Tianqing Pharmaceutical divulges AXL inhibitors

Dec. 22, 2021

Esteve patents dual CACNA2D1/SIGMAR1 ligands

Dec. 22, 2021

Histone-lysine N-methyltransferase 2A inhibitors discovered at Novartis

Dec. 22, 2021

Chiesi identifies new discoidin domain-containing receptor inhibitors

Dec. 22, 2021

RET inhibitor SYHA-1815 induces G1 cell cycle arrest through c-MYC downregulation

Dec. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...